Search

Your search keyword '"Ataxia Telangiectasia blood"' showing total 106 results

Search Constraints

Start Over You searched for: Descriptor "Ataxia Telangiectasia blood" Remove constraint Descriptor: "Ataxia Telangiectasia blood"
106 results on '"Ataxia Telangiectasia blood"'

Search Results

1. Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia.

2. Hematopoietic Stem Cell Transplantation Restores Naïve T-Cell Populations in Atm -Deficient Mice and in Preemptively Treated Patients With Ataxia-Telangiectasia.

3. Antioxidant Defense, Redox Homeostasis, and Oxidative Damage in Children With Ataxia Telangiectasia and Nijmegen Breakage Syndrome.

4. Inflammation and transcriptional responses of peripheral blood mononuclear cells in classic ataxia telangiectasia.

5. Assessing cardiovascular risk in ATM heterozygotes.

6. In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia.

7. Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.

8. Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment.

9. Serum Interleukin-6 Levels and Pulmonary Function in Ataxia-Telangiectasia.

10. Liver Disease in Pediatric Patients With Ataxia Telangiectasia: A Novel Report.

11. Body composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study.

12. Blood metal levels and related antioxidant enzyme activities in patients with ataxia telangiectasia.

13. Multi-drugs resistant acne rosacea in a child affected by Ataxia-Telangiectasia: successful treatment with Isotretinoin.

14. Risk of Atherosclerosis in Patients with Ataxia Telangiectasia.

15. The relationship between nutritional status, vitamin A and zinc levels and oxidative stress in patients with ataxia-telangiectasia.

16. Growth retardation and growth hormone deficiency in patients with Ataxia telangiectasia.

17. Twelve novel Atm mutations identified in Chinese ataxia telangiectasia patients.

18. Molecular defects in Moroccan patients with ataxia-telangiectasia.

19. Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia.

20. A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity.

21. Hereditary persistence of alpha-fetoprotein.

22. DNA repair alterations in children with pediatric malignancies: novel opportunities to identify patients at risk for high-grade toxicities.

23. Elevated serum IL-8 levels in ataxia telangiectasia.

24. Ataxia-telangiectasia: atypical presentation and toxicity of cancer treatment.

25. Ataxia telangiectasia with hepatocellular carcinoma.

26. Alpha fetoprotein is increasing with age in ataxia-telangiectasia.

27. Dysgerminoma in a child with ataxia-telangiectasia.

28. Glutathione levels in blood from ataxia telangiectasia patients suggest in vivo adaptive mechanisms to oxidative stress.

29. [Ataxia-telangiectasia syndrome. Clinical and diagnostic aspects].

30. Growth factor deficiency in patients with ataxia telangiectasia.

31. Immunoassay to measure ataxia-telangiectasia mutated protein in cellular lysates.

32. Unusual and severe disease course in a child with ataxia-telangiectasia.

33. Signal transduction through the B cell antigen receptor is normal in ataxia-telangiectasia B lymphocytes.

34. Neurodegeneration is associated to changes in serum insulin-like growth factors.

36. Detection of individual differences in radiation-induced apoptosis of peripheral blood lymphocytes in normal individuals, ataxia telangiectasia homozygotes and heterozygotes, and breast cancer patients after radiotherapy.

37. The use of cryopreserved lymphocytes in assessing inter-individual radiosensitivity with the micronucleus assay.

38. Immunoblot analysis for laboratory diagnosis of ataxia-telangiectasia: use of Epstein-Barr virus-transformed or phytohemagglutinin-stimulated lymphoblasts for detection of ATM protein.

39. Altered apoptotic profiles in irradiated patients with increased toxicity.

40. Anti-oxidative capacity in patients with ataxia telangiectasia.

41. Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia.

42. Hepatic veno-occlusive disease in ataxia-telangiectasia.

43. Inhibition of the Mr 70,000 S6 kinase pathway by rapamycin results in chromosome malsegregation in yeast and mammalian cells.

44. Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein.

45. Possible control of cell death pathways in ataxia telangiectasia. A case report.

46. Diagnosis of ataxia telangiectasia with the glycophorin A somatic mutation assay.

47. Vitamin E serum levels are normal in ataxia telangiectasia (Louis-Bar disease).

48. Ataxia telangiectasia heterozygotes and patients display increased fluidity and decrease in contents of sulfhydryl groups in red blood cell membranes.

49. Effects of topoisomerase II inhibition in lymphoblasts from patients with progeroid and "chromosome instability" syndromes.

50. Radiation-induced G2 delay and spontaneous chromosome aberrations in ataxia-telangiectasia homozygotes and heterozygotes.

Catalog

Books, media, physical & digital resources